RecruitingPhase 2NCT05842044

NSAID Use After Robotic Partial Nephrectomy

NSAID Use After Robotic Partial Nephrectomy (No-PAIN): a Randomized, Controlled Trial


Sponsor

University of Miami

Enrollment

110 participants

Start Date

Sep 15, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

The purpose of this study is to see how effective non-steroidal anti-inflammatory drugs (NSAIDs) are at controlling pain without side effects in participants after robotic-assisted partial nephrectomy.


Eligibility

Min Age: 18 YearsMax Age: 99 Years

Inclusion Criteria3

  • Patients undergoing uncomplicated robotic assisted laparoscopic partial nephrectomy for renal mass at the University of Miami Hospital and Network Sites (Deerfield Beach, Plantation, Lennar (Coral Gables), and Kendal).
  • Age 18-99.
  • Ability to understand and the willingness to sign a written informed consent document.

Exclusion Criteria9

  • Allergy to NSAIDs
  • Myocardial infarction or unstable angina within 12 months.
  • Any history of coronary artery bypass graft surgery.
  • History or active peptic ulcer disease, gastrointestinal (GI) bleeding, GI perforation. History of bleeding disorder. Glomerular filtration rate (GFR) \< 60 mL/min/1.73m2 (Modification of Diet in Renal Disease (MDRD) equation).
  • Taking any anti-platelet or anti-coagulation medications concurrently (e.g. warfarin, aspirin, clopidogrel, rivaroxaban etc.)
  • Chronic opioid use (use within 12 weeks) or history of opioid use disorder.
  • Solitary kidney.
  • Pregnancy.
  • Inability to give informed consent or unable to meet requirement of the study for any reason.

Interventions

DRUGKetorolac

15-30mg Ketorolac administered via injection during intraoperative period every six (6) hours during post-surgery (inpatient) period.

DRUGAcetaminophen

1000mg Acetaminophen administered orally during preoperative period. Standardized regimen of Acetaminophen administered during post-surgery (inpatient) period, during postoperative follow-up period.

DRUGOxycodone

Standardized regimen of Oxycodone administered orally (PO) on demand for moderate pain during post-surgery (inpatient) period. At discharge 5mg Oxycodone will be administered to participants on demand if pain score is greater than 7, or if participant required greater than 25mg Oxycodone during the hospitalization.

DRUGHydromorphone

Standardized regimen of Hydromorphone administered intravenously (IV) on demand for severe pain during post-surgery (inpatient) period.

DRUGIbuprofen

400mg Ibuprofen tablets administered orally (PO) every eight (8) hours for 5 days.


Locations(1)

University of Miami

Miami, Florida, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05842044


Related Trials